THE APPLICATION OF PHARMACOMETABOLOMICS TO PREDICT THE PHARMACOKINETICS OF TACROLIMUS IN HEALTHY KOREAN SUBJECTS.

被引：0
|
作者：
Lim, M. [1 ]
Phapale, P. [1 ]
Kim, S. [1 ]
Lee, H. [1 ]
Lee, W. [1 ]
Yoon, Y. [1 ]
机构：
[1] Kyungpook Natl Univ Hosp, Clin Trial Ctr, Taegu, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [1] Effect of rifampin on the pharmacokinetics of rosiglitazone in Korean healthy subjects.
    Park, J
    Kim, K
    Jung, W
    Kim, S
    Shin, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P34 - P34
  • [2] The effects of pomegranate juice on pharmacokinetics of simvastatin in healthy Korean subjects.
    Yeo, C
    Shon, J
    Liu, K
    Lee, D
    Yoon, Y
    Shin, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P23 - P23
  • [3] The pharmacokinetics and pharmacodynamics of prasugrel in healthy Chinese, Japanese, and Korean subjects compared with healthy Caucasian subjects.
    Small, D. S.
    Kothare, P. A.
    Yuen, E. S.
    Li, Y. G.
    Winters, K. J.
    Farid, N. A.
    Ni, L.
    Salazar, D. E.
    Payne, C. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S56 - S57
  • [4] PHARMACOKINETICS AND TOLERABILITY OF BALOXAVIR MARBOXIL AFTER A SINGLE ADMINISTRATION IN HEALTHY KOREAN SUBJECTS.
    Kim, B.
    Kim, Y.
    Lee, S.
    Yoon, D.
    Kim, Y.
    Lee, S.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S92 - S92
  • [5] Rimonabant pharmacokinetics in healthy and obese subjects.
    Turpault, S
    Kanamaluru, V
    Lockwood, GF
    Bonnet, D
    Newton, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P50 - P50
  • [6] PHARMACOKINETICS AND PHARMACODYNAMICS OF A SINGLE INTRAVENOUS DOSE OF HM10760A IN HEALTHY KOREAN SUBJECTS.
    Kim, S.
    Lee, S.
    Yoon, S.
    Lim, K. S.
    Shin, S. G.
    Yu, K. S.
    Jang, I. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S81 - S82
  • [7] EFFECT OF RIFAMPIN ON THE PHARMACOKINETICS OF ERTUGLIFLOZIN IN HEALTHY SUBJECTS.
    Kumar, V.
    Sahasrabudhe, V.
    Liang, Y.
    Matschke, K.
    Shi, H.
    Fountaine, R. J.
    Hickman, A.
    Saur, D.
    Terra, S. G.
    Cutler, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S47 - S47
  • [8] The pharmacokinetics of tesaglitazar (GALIDA™) in healthy male subjects.
    Ericsson, H
    Samuelsson, S
    Bergstrand, S
    Fryklund, L
    Hamrén, B
    Heijer, M
    Öhman, P
    DIABETOLOGIA, 2003, 46 : A292 - A292
  • [9] Pharmacokinetics of Tapentadol in Healthy Elderly and Young Subjects.
    Smit, J. W.
    Haeufel, T.
    Ravenstijn, P.
    Brett, M.
    Kleideiter, E.
    Mangold, B.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1079 - 1079
  • [10] Effect of CYP2C9 polymorphism on the pharmacokinetics of candesartan in healthy Korean subjects.
    Lee, Seok-Yong
    Bae, Jung-Woo
    Han, Ho-Kyun
    Kim, Nam-Tae
    Lee, Jin-Hee
    Jang, Choon-Gon
    Jung, Dong-Won
    Lee, Hwan-Joo
    Choi, Sun-Ok
    Kim, Ok-Hee
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 235 - 235
12345